SYMPATICO: safety and efficacy of ibrutinib plus venetoclax for R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:18 3 years ago 87 Скачать Далее
SYMPATICO: ibrutinib combined with venetoclax in patients with R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:37 6 months ago 213 Скачать Далее
The SYMPATICO trial: ibrutinib plus venetoclax in TP53-mutated MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:28 1 month ago 160 Скачать Далее
Ibrutinib plus obinutuzumab/venetoclax in R/R MCL: OAsIs results VJHemOnc – Video Journal of Hematology & HemOnc 1:08 5 years ago 159 Скачать Далее
SYMPATICO: Primary analysis results of ibrutinib plus venetoclax for patients with R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:52 7 months ago 146 Скачать Далее
SYMPATICO: Is ibrutinib combined with venetoclax safe and effective in patients with R/R MCL? Lymphoma Hub 3:57 6 months ago 121 Скачать Далее
Ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:21 2 years ago 214 Скачать Далее
The safety of venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:39 1 year ago 207 Скачать Далее
Michael Wang, MD, Discusses the SYMPATICO Study on Ibrutinib Plus Venetoclax in MCL Blood Cancers Today 3:25 7 months ago 146 Скачать Далее
Dr. Tam on the Toxicity of Ibrutinib Plus Venetoclax in MCL OncLive 1:08 6 years ago 243 Скачать Далее
ZILO-301: Phase III study of zilovertamab + ibrutinib vs ibrutinib in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:23 2 years ago 305 Скачать Далее
Acalabrutinib plus venetoclax and rituximab in MCL & the importance of chemotherapy-free regimens VJHemOnc – Video Journal of Hematology & HemOnc 3:42 1 year ago 269 Скачать Далее
OAsIs trial update: ibrutinib, venetoclax plus obinutuzumab in newly diagnosed MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:30 4 years ago 195 Скачать Далее
Dr. Tam on the Toxicities of Ibrutinib Plus Venetoclax in MCL OncLive 1:08 7 years ago 200 Скачать Далее
Durable responses to ibrutinib and venetoclax in R/R MCL: 3-year AIM update VJHemOnc – Video Journal of Hematology & HemOnc 3:06 4 years ago 77 Скачать Далее
Venetoclax, lenalidomide and rituximab in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:22 3 years ago 66 Скачать Далее
CAPTIVATE: fixed-duration ibrutinib plus venetoclax in patients with CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 1:23 2 years ago 167 Скачать Далее
Dr. Ritchie on Immunological Response to Venetoclax/Ibrutinib in R/R MCL OncLive 1:27 4 years ago 142 Скачать Далее
Venetoclax: an unmet need in R/R mantle cell lymphoma after BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 3:27 5 years ago 211 Скачать Далее
Dr. Ritchie on the Immunologic Impact of Long-Term Venetoclax/Ibrutinib in R/R MCL OncLive 1:09 4 years ago 54 Скачать Далее
